Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Antitype chi

ABSTRACT: Antitype chi overview

PROVIDER: PRJNA902475 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	ERR10123714_1.fastq.gz	Fastqsanger.gz
	ERR10123714_2.fastq.gz	Fastqsanger.gz
	ERR10115641.fastq.gz	Fastqsanger.gz
	ERR10890705_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

ilAntChix

Project description:Antitype chi

| PRJEB55575 | ENA

ilAntChix2

Project description:Antitype chi genome assembly, ilAntChix2

| PRJEB57611 | ENA

ilAntChix

Project description:Antitype chi, genomic and transcriptomic data

| PRJEB55574 | ENA

ilAntChix2 alternate haplotype

Project description:Antitype chi genome assembly, ilAntChix2, alternate haplotype

| PRJEB57612 | ENA

Medical Tai Chi Exercise Healing in Treating mCRC Patients

Project description:As a traditional martial art in China, Tai Chi Chuan has excellent health benefits along with its combat function.Studies have shown that Tai Chi as an exercise prescription can significantly reduce the incidence of cancer, but the complexity of Tai Chi Chuan routines, poor disease targeting, and the lack of traditional internal mental and physical training method limit the healing of tumours and other diseases. For this reason, we have established the Medical Tai Chi Exercise Healing System（MTCEH）, which integrates Tai Chi exercise, traditional Chinese internal mental and physical training method, rehabilitation medicine and sports medicine methods, on the basis of evidence-based medicine and with the aim of targeting different tumour treatments. With the characteristics of easily learning, internal and external training, and individualised treatment of tumours, this series of routines effectively combines traditional oriental Tai Chi martial arts with tumour treatment, which opens up a beautiful and mysterious oriental healing journey for integrative medicine.

| 114987 | ecrin-mdr-crc

ilAntChix2.Spiroplasma_sp_1

Project description:Spiroplasma endosymbiont of Antitype chi genome assembly, ilAntChix2.Spiroplasma_sp_1

| PRJEB74376 | ENA

Coleofasciculus sp. CHI DSM 104232

Project description:cyanosphere of Coleofasciculus sp. CHI DSM 104232 culture

| PRJNA993444 | ENA

Limihaloglobus sulfuriphilus strain:SM-Chi-D1

Project description:Limihaloglobus sulfuriphilus strain:SM-Chi-D1 Genome sequencing and assembly

| PRJNA369380 | ENA

Acinetobacter bereziniae CHI-40-1

Project description:Whole genome sequence of Acinetobacter bereziniae CHI-40-1, harbouring plasmid pNDM-40-1.

| PRJEB7120 | ENA

Nuclear magnetic resonance-based metabolomics approach to evaluate the prevention effect of Camellia nitidissima Chi on colitis-associated carcinogenesis

Project description:Colorectal cancer (CRC) is one of the most common malignant tumors worldwide, occurring in the colon or rectum portion of large intestine. With marked antioxidant, anti-inflammation and anti- tumor activities, Camellia nitidissima Chi has been used as an effective treatment of cancer. The azoxymethane/dextran sodium sulfate (AOM/DSS) induced CRC mice model was established and the prevention effect of Camellia nitidissima Chi extracts on the evolving of CRC was evaluated by gross examination, histopathological inspection, serum biochemistry analysis, combined with nuclear magnetic resonance (NMR)-based metabolomics and correlation network analysis. The results showed that Camellia nitidissima Chi extracts could significantly inhibit AOM/DSS induced CRC, relieve the colonic pathology and ameliorate the serum biochemistry, and could signiﬁcantly reverse the disturbed metabolism towards the normal state. Moreover, the butanol fraction showed a better efficiency than the water-soluble fraction of Camellia nitidissima Chi. The study pave the way for further development of Camellia nitidissima Chi extracts as a potent CRC inhibitor. In this work, rats were divided into control group, carcinoma group, and two drug groups of JHC and CNC. The acronyms JHC means the water-soluble fraction of Camellia nitidissima Chi. The acronyms CNC means the butanol fraction of Camellia nitidissima Chi.

2017-05-21 | ST000782 | MetabolomicsWorkbench

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data